Delivery Order SPE2DB25D3504-SPE2DB25FVVXV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,183.42 to AmerisourceBergen Drug Corp for Trintellix 5 mg tablets (30-count packages) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,427.12 for 30 tablets of Trintellix 20 mg on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trintellix is a psychiatric medication used to treat major depressive disorder, reflecting the breadth...
- The Defense Logistics Agency awarded a delivery order valued at $1,621.39 to AmerisourceBergen Drug Corp for 30 tablets of Trintellix 5 mg, a pharmaceutical product used in the treatment of major depressive disorder. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 12, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trintellix 5 mg tablets (30-count) with a contract ceiling value of $4,978.44. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,442.25, is for the delivery of Trintellix 10 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,145.70 firm fixed-price delivery order is for the medication Trintellix 20 mg tablet, with a period of performance through April 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This...
- The Defense Logistics Agency (DLA) awarded a $2,343.74 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trintellix 20 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trintellix 10 mg tablets (30-count packaging) under a firm fixed-price contract with a ceiling value of $1,309.08. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,803.14 firm fixed-price delivery order is for the supply of TRINTELLIX 10 MG TABLET 30S, a medication used in the treatment of major depressive disorder. The award has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $1,529.88 firm fixed price contract is for the supply of 4568661119 TRINTELLIX 10 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 30, 2025. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVXVDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,208.34 for 30 tablets of Trintellix 20 mg, a prescription antidepressant used to treat major depressive disorder. This firm fixed price delivery order, awarded on August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award involved no set-aside designation, indicating it was competitively awarded through open procurement processes. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order is part of AmerisourceBergen's ongoing role as a primary pharmaceutical distributor for federal military and veteran healthcare systems. The company's comprehensive DLA contract vehicle enables it to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic areas to support Defense Health Agency operations and other federal healthcare programs. AmerisourceBergen's federal contract portfolio demonstrates its capability to fulfill critical medical supply needs for the Department of Defense through both high-value specialty medications and routine pharmaceutical deliveries on a global scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/11/25 |